1
|
Giannouli V, Lougiakis N, Kostakis IK, Pouli N, Marakos P, Skaltsounis AL, Horne DA, Nam S, Gioti K, Tenta R. Design and Synthesis of New Substituted Pyrazolopyridines with Potent Antiproliferative Activity. Med Chem 2020; 16:176-191. [DOI: 10.2174/1573406415666190222130225] [Citation(s) in RCA: 5] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/19/2018] [Revised: 01/24/2019] [Accepted: 02/08/2019] [Indexed: 12/15/2022]
Abstract
Background:
Purine isosteres are often endowed with interesting pharmacological
properties, due to their involvement in cellular processes replacing the natural purines. Among
these compounds, pyrazolopyridines are under active investigation for potential anticancer properties.
Objective:
Based on previously discovered substituted pyrazolopyridines with promising antiproliferative
activity, we designed and synthesized new, suitably substituted analogues aiming to investigate
their potential activity and contribute to SAR studies of this class of bioactive compounds.
Methods:
The new compounds were synthesized using suitably substituted 2-amino-4-picolines,
which upon ring-closure provided substituted pyrazolo[3,4-c] pyridine-5-carbonitriles that served
as key intermediates for the preparation of the target 3,5,7 trisubstituted derivatives. The antiproliferative
activity of 31 new target derivatives was evaluated against three cancer cell lines (MIA
PaCa-2, PC-3 and SCOV3), whereas cell-cycle perturbations of exponentially growing PC-3 cells,
using three selected derivatives were also performed.
Results:
Eight compounds displayed IC50 values in the low μM range, allowing the extraction of
interesting SAR’s. Two of the most potent compounds against all cell lines share a common pattern,
by accumulating cells at the G0/G1 phase. From this project, a new carboxamidine-substituted
hit has emerged.
Conclusion:
Among the new compounds, those possessing the 3-phenylpyrazolo[3,4-c]pyridine
scaffold, proved to be worth investigating and the majority of them showed strong cytotoxic activity
against all cell lines, with IC50 values ranging from 0.87-4.3 µM. A carboxamidine analogue
that resulted from the synthetic procedure, proved to be highly active against the cancer cells and
could be considered as a useful lead for further optimization.
Collapse
Affiliation(s)
- Vassiliki Giannouli
- Division of Pharmaceutical Chemistry, Department of Pharmacy, National and Kapodistrian University of Athens, Panepistimiopolis-Zografou, Athens 15771, Greece
| | - Nikolaos Lougiakis
- Division of Pharmaceutical Chemistry, Department of Pharmacy, National and Kapodistrian University of Athens, Panepistimiopolis-Zografou, Athens 15771, Greece
| | - Ioannis K. Kostakis
- Division of Pharmaceutical Chemistry, Department of Pharmacy, National and Kapodistrian University of Athens, Panepistimiopolis-Zografou, Athens 15771, Greece
| | - Nicole Pouli
- Division of Pharmaceutical Chemistry, Department of Pharmacy, National and Kapodistrian University of Athens, Panepistimiopolis-Zografou, Athens 15771, Greece
| | - Panagiotis Marakos
- Division of Pharmaceutical Chemistry, Department of Pharmacy, National and Kapodistrian University of Athens, Panepistimiopolis-Zografou, Athens 15771, Greece
| | - Alexios-Leandros Skaltsounis
- Division of Pharmacognosy & Natural Products Chemistry, Department of Pharmacy, National and Kapodistrian University of Athens, Panepistimiopolis-Zografou, Athens 15771, Greece
| | - David A. Horne
- Molecular Medicine, Beckman Research Institute, City of Hope Comprehensive Cancer Center, 1500 East Duarte Road, Duarte, CA, 91010, United States
| | - Sangkil Nam
- Molecular Medicine, Beckman Research Institute, City of Hope Comprehensive Cancer Center, 1500 East Duarte Road, Duarte, CA, 91010, United States
| | - Katerina Gioti
- Department of Nutrition & Dietetics, School of Health Sciences and Education, Harokopio University, Athens 17671, Greece
| | - Roxane Tenta
- Department of Nutrition & Dietetics, School of Health Sciences and Education, Harokopio University, Athens 17671, Greece
| |
Collapse
|
2
|
Argyros O, Karampelas T, Varela A, Asvos X, Papakyriakou A, Agalou A, Beis D, Davos CH, Fokas D, Tamvakopoulos C. Targeting of the breast cancer microenvironment with a potent and linkable oxindole based antiangiogenic small molecule. Oncotarget 2018; 8:37250-37262. [PMID: 28422745 PMCID: PMC5514907 DOI: 10.18632/oncotarget.16763] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/29/2016] [Accepted: 03/22/2017] [Indexed: 01/11/2023] Open
Abstract
The clinical efficacy of antiangiogenic small molecules (e.g., sunitinib) in breast carcinoma has largely failed with substantial off-target toxicity. We rationally designed and evaluated preclinically a novel sunitinib analogue, SAP, with favourable pharmacological properties and the ability to be readily conjugated to a targeting peptide or antibody for active tumour targeting. SAP was evaluated in silico and in vitro in order to verify target engagement (e.g., VEGFR2). Pharmacokinetic and biodistribution parameters were determined in mice using LC-MS/MS. SAP efficacy was tested in two breast cancer xenograft and two syngeneic animal models and pharmacodynamic evaluation was accomplished using phosphokinase assays and immunohistochemistry. Cardiac and blood toxicity of SAP were also monitored. SAP retained the antiangiogenic and cytotoxic properties of the parental molecule with an increased blood exposure and tumor accumulation compared to sunitinib. SAP proved efficacious in all animal models. Tumors from SAP treated animals had significantly decreased Ki-67 and CD31 markers and reduced levels of phosphorylated AKT, ERK and S6 compared to vehicle treated animals. In mice dosed with SAP there was negligible hematotoxicity, while cardiac function measurements showed a reduction in the percentage left ventricular fractional shortening compared to vehicle treated animals. In conclusion, SAP is a novel rationally designed conjugatable small antiangiogenic molecule, efficacious in preclinical models of breast cancer.
Collapse
Affiliation(s)
- Orestis Argyros
- Division of Pharmacology-Pharmacotechnology, Biomedical Research Foundation Academy of Athens, Athens, 11527, Greece
| | - Theodoros Karampelas
- Division of Pharmacology-Pharmacotechnology, Biomedical Research Foundation Academy of Athens, Athens, 11527, Greece
| | - Aimilia Varela
- Cardiovascular Research Laboratory, Clinical, Experimental Surgery and Translational Research Center, Biomedical Research Foundation Academy of Athens, Athens, 11527, Greece
| | - Xenophon Asvos
- Laboratory of Medicinal Chemistry, Department of Materials Science and Engineering, University of Ioannina, Ioannina, 45110, Greece
| | - Athanasios Papakyriakou
- Laboratory of Chemical Biology of Natural Products and Designed Molecules, Institute of Physical Chemistry, N.C.S.R "Demokritos", Athens, 15310, Greece
| | - Adamantia Agalou
- Developmental Biology, Biomedical Research Foundation Academy of Athens, Athens, 11527, Greece
| | - Dimitris Beis
- Developmental Biology, Biomedical Research Foundation Academy of Athens, Athens, 11527, Greece
| | - Constantinos H Davos
- Cardiovascular Research Laboratory, Clinical, Experimental Surgery and Translational Research Center, Biomedical Research Foundation Academy of Athens, Athens, 11527, Greece
| | - Demosthenes Fokas
- Laboratory of Medicinal Chemistry, Department of Materials Science and Engineering, University of Ioannina, Ioannina, 45110, Greece
| | - Constantin Tamvakopoulos
- Division of Pharmacology-Pharmacotechnology, Biomedical Research Foundation Academy of Athens, Athens, 11527, Greece
| |
Collapse
|
3
|
Fiorentino S, Urueña C, Lasso P, Prieto K, Barreto A. [Effect of miskleron (clofibrate) on dimethylhydrazine induction of intestinal tumors in rats]. Front Oncol 1981; 10:1334. [PMID: 32850424 PMCID: PMC7426739 DOI: 10.3389/fonc.2020.01334] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/25/2020] [Accepted: 06/26/2020] [Indexed: 12/18/2022] Open
Abstract
In this review, we report on the complexity of breast cancer stem cells as key cells in the emergence of a chemoresistant tumor phenotype, and as a result, the appearance of distant metastasis in breast cancer patients. The search for mechanisms that increase sensitivity to chemotherapy and also allow activation of the tumor-specific immune response is of high priority. As we observed throughout this review, natural products isolated or in standardized extracts, such as P2Et or others, could act synergistically, increasing tumor sensitivity to chemotherapy, recovering the tumor microenvironment, and participating in the induction of a specific immune response. This, in turn, would lead to the destruction of cancer stem cells and the decrease in metastasis. Source of Data: Relevant studies were found using the following keywords or medical subject headings (MeSH) in PubMed, and Google Scholar: “immune response” and “polyphenols” and “natural products” and “BCSC” and “therapy” and “metabolism” and “immunogenic cell death.” The focus was primarily on the most recent scientific publication.
Collapse
|